Journal News

MCP: Guidelines for reporting
complex spectra

Laurel Oldach
Sept. 1, 2018

The editors of the journal Molecular & Cellular Proteomics are seeking feedback from the proteomics community on draft guidelines for publishing proteomics studies that use data-independent acquisition, or DIA, methods. The draft guidelines can be accessed from the journal’s homepage. Comments will be accepted until the end of September.

Steven Carr is deputy editor of MCP and senior director of proteomics at the Broad Institute. “DIA is a rapidly growing research approach that can be employed on a wide variety of instrument platforms,” he said. “As such, it is important to establish rules to make sure it is properly applied.”

DIA is used to collect tandem mass spectrometry data. It offers broad coverage of the proteome with high run-to-run reproducibility.

Courtesy of Sue Weintraub
Participants at the DIA workshop in San Diego paused for a photo.

Mass spectrometers sort the ions from a sample based on their mass-to-charge ratio. In tandem mass spectrometry, there are two ionization and sorting steps. For reliable identification of a molecule, you need to know its intact precursor ion mass and also the masses produced when it is fragmented. Most strategies involve fragmenting a single precursor ion at a time.

Selection of a precursor ion can be based on observation of a peak in the first spectrum (a strategy known as data-dependent acquisition, or DDA), or it can be from a list of predetermined components of interest, i.e., targeted analysis. However, both of these approaches select only a subset of the components present for fragmentation analysis. In DIA, the whole mass range is fragmented over a series of scans. This provides fragmentation information about all components, but fragmenting multiple components at the same time produces complex spectra made of heterogeneous precursors.

With technical advances in instrumentation and computation, DIA approaches are growing in popularity, particularly for quantitative studies of sets of related samples. However, because the spectra collected using DIA are significantly more complex than data from other approaches, they can be more difficult to interpret. Complicating the situation further, there are many competing techniques for collecting DIA data, few of which have been compared directly, and researchers have yet to develop fieldwide standards around how to interpret and report results.

MCP is taking steps to ensure that future data will be described more systematically. The editors brought together 25 DIA experts from academia and industry at a satellite workshop in San Diego after the close of the American Society for Mass Spectrometry’s 2018 meeting in June. The guidelines drafted at this workshop aim to help researchers write a thorough description of how DIA data were collected and interpreted, rendering researchers’ conclusions easier to evaluate.

Among the workshop’s organizers was Robert Chalkley of the University of California, San Francisco, MCP data management editor. “When we publish the draft, we will give the opportunity for anyone in the community to send in their comments and suggestions,” he said.

MCP’s reporting guidelines for other types of mass spectrometry study have been adopted widely by other journals. MCP’s editors hope to continue to lead the field in producing guidelines that aim to allow independent assessment of the reliability of published data sets.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Journal News

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder

Sept. 16, 2025

Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Journal News

How sugars shape Marfan syndrome

Sept. 10, 2025

Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.